Bal Pharma Ltd
Bal Pharma Ltd (BALPHARMA)

Bal Pharma Ltd (BALPHARMA)


Key Stats

Day's Price Range
52-Week Price Range
1 Month Return-1.26 %
3 Month Return4.18 %
1 Year Return-11.6 %

Company Financials

  • Quarterly
  • Annual
Value in ₹ crore

Peer Comparsion

Rank 180
Rank 213
Rank 219
Dividend Yield
Rank 49
Rank 258
Price To Book Ratio
Rank 136
Debt To Asset
Rank 39

Company Information

Bal Pharma BPL a member of the Mcro Laboratories group was incorporated as a private limited company in May 87. In Mar.90 BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which BPL commenced manufacturing formulations.BPL manufactures and markets pharmaceutical formulations paracetamol aluminium hydroxide povidone iodine alprazolam gliclazide griseofulvin lactobacillus rifampicin piroxicam amoxycillin etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.During 199798 the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July 1997 the unit has become a division of Bal Pharma Limited. The companys product range has been expanded with the introduction of AZIWIN CAFIMOL CORTIDERM.The company has added further product range Zanovid Aziwin Dry Syrup Meloxi Ocium M Progit MPS in its ethical division during 19992000. As part of the expansion of the product range the company has introduced Cardiac Specialities Products. To market these products a new division named SERVETUS has started functioning during 2001. New products like AmilorideBenzydamine and Ebastine were rolled into the market during 2002.
OrganisationBal Pharma Ltd